RPS Science and Research Summit 2019
Friday 8th February 2019, etc.Venues County Hall, London
In collaboration with the Joint Pharmaceutical Analysis Group (JPAG) and The Academy of Pharmaceutical Sciences (APS)
Chaired by RPS Chief Scientist Gino Martini and featuring keynote speakers Dame Sally Davies and Professor Molly Stevens, the RPS Science and Research Summit 2019 showcased the latest ground-breaking developments in pharmacy, research and pharmaceutical sciences , exploring some of the most pressing challenges and opportunities for the future of healthcare.
Discussion highlights included:
- The implementation of the Falsified Medicines Directive (FMD) on 9th February 2019
- The UK's Antimicrobial Resistance (AMR) strategy for 2019 and beyond
- Insight into the newest regenerative medicines and how they will affect pharmacy
- The impact of Artificial Intelligence (AI) on pharmacy
- What medicines regulation could look like post-Brexit
Professor Dame Sally Davies, Chief Medical Officer for England
Dame Sally was appointed Chief Medical Officer (CMO) for England and Chief Medical Adviser to the UK Government in March 2011, having held the post on an interim basis since June 2010. Dame Sally is an independent adviser to the UK Government on medical matters, with particular responsibilities regarding Public Health. From 2004-2016, Dame Sally was the Chief Scientific Adviser (CSA) for the Department of Health (DH), where she was actively involved in NHS R&D from its establishment and founded the National Institute for Health Research (NIHR). In 2013, she became a Non-Executive Director of Genomics England Ltd, wholly owned and funded by DH, to sequence 100,000 whole genomes from NHS patients by 2017. Dame Sally is also a non-executive member of the UK Research and Innovation Board, on which she sits in a personal capacity due to her civil servant status.
Dame Sally was a member of the World Health Organization (WHO) Executive Board 2014-2016 and has led delegations to WHO summits and forums since 2004. She advises many governments and organisations on health and policy and holds positions on a number of Boards.
Advocating globally on AMR, Dame Sally has spoken at numerous events, including World Health Assembly side-events, the G8 Science Ministers’ meeting in 2015, the Global Health Security Initiative in 2015 and the UN General Assembly side-event in 2016. She was Chair of the 2013 AMR forum at the World Innovation Summit for Health (WISH) and is currently Chair of the WHO Strategic and Technical Advisory Group on AMR. Most recently, Dame Sally has been appointed a co-convener of the UN Interagency Coordination Group on AMR, set up in response to the AMR declaration made at UNGA 2016.
Dame Sally received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA, in 2015.
Professor Molly Stevens, Professor of Biomedical Materials and Regenerative, Imperial College London
Molly M. Stevens is Professor of Biomedical Materials and Regenerative Medicine, and Research Director for Biomedical Material Sciences in the Department of Materials, Department of Bioengineering and the Institute of Biomedical Engineering at Imperial College London. She received her PhD from The University of Nottingham in 2000, working within the School of Pharmaceutical Sciences. Molly conducted her postdoctoral research within the Department of Chemical Engineering at MIT in the labs of Prof Robert Langer, where she co-developed innovative techniques for the regenerative of bone and other tissues. She joined Imperial College in 2004 and was promoted as Professor in 2008. Research in the Stevens Programme focuses on designing and developing innovative bio-inspired materials for applications in regenerative medicine, tissue engineering and biosensing.
Molly Stevens’ research has been recognised by over 20 major awards, including the 2016 Clemson Award for Basic Research from the Society for Biomaterials, the EU40 Prize for best material scientist under the age of 40, a listing in The Times as one of the top 10 scientists under 40 and the European Life Sciences 2014 Research Group of the Year Award, amongst many others. She was recently elected to the Fellowship of the Royal Academy for Engineering and delivered the Clifford Paterson Lecture for the Royal Society in 2012. She has previously served on the Board of Reviewing Editors for Science and is Associate Editor of ACS Nano. Further information on the Stevens Group can be found at http://www.stevensgroup.org.